QMS Medical Allied Services, a healthcare management solutions company, opened its Rights Issue on 12 September 2025 to raise ₹12.5 crore. The Issue comprises 14,87,500 equity shares of face value ₹10 each, offered at an Issue Price of ₹81 per share (including a premium of ₹71 per share).
According to the company, the Rights Issue ratio has been set at 1:12, meaning one equity share will be issued for every 12 equity shares held by shareholders. The total Issue size stands at ₹12.05 crore. The record date was 4 September 2025, and the renunciation of rights entitlement is set for 17 September 2025. The Issue will remain open from 12 September 2025 to 22 September 2025.
QMS Medical Allied Services stated that the proceeds from the Rights Issue will be utilised to strengthen its growth trajectory. Of the total funds raised, ₹10 crore will be invested towards acquiring an additional 25 per cent stake in its subsidiary, Saarathi Healthcare Private Limited, increasing QMS Medical Allied Services’ holding to 76 per cent. The remaining funds will be deployed towards working capital requirements and general corporate purposes.
Mahesh Makhija, Founder, Chairman and Managing Director, QMS Medical Allied Services, said, “The Rights Issue will support our planned acquisition of an additional 25 per cent stake in Saarathi Healthcare Private Limited, further consolidating our position in the value-added segment of the healthcare industry. This strategic investment reinforces our commitment to expanding QMS Medical Allied Services’ footprint in high-growth verticals, enhancing operational synergies, and unlocking long-term value for all stakeholders.”
Makhija added, “India’s healthcare sector continues to experience unprecedented growth, driven by rising demand for advanced medical solutions. At QMS Medical Allied Services, we remain steadfast in our mission to deliver accessible, high-quality, and dependable healthcare products and services across the country. This Rights Issue is not just a step towards accelerating our strategic initiatives, but also a valuable opportunity for our shareholders to strengthen their association with QMS Medical Allied Services and participate in our journey of sustained growth and innovation.”